Data: 08/08/2026
Total encontrado: 17
1/17US=159 / Tese/FAP
Lima Junior CLH. Expressão de ciclina D1, CDK4, p16ink4, p21WAF1, integrina αVβ3, MMP-2 e MMP-9 em melanoma cutâneo primário de pacientes submetidos à pesquisa de linfonodo sentinela. São Paulo, 2006. 102 p. Dissertação(Mestrado)-Fundação Antonio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2006/CristianoLuizHortaLimaJunior/CristianoLuizHortaLimaJrmestrado.pdf

Curriculum Lattes

MELANOMA; BIOPSIA DE LINFONODO SENTINELA; IMUNOHISTOQUIMICA; CICLINA D1; PROTEINAS CDK; PROTEINA P16; PROTEINA P21; METALOPROTEINASES; INTEGRINAS; TISSUE MICRO ARRAY

2/17US=94 / Biol/Mol
Matthews DJ, Gerritsen ME. Kinases and cancer. In: ___. Targeting protein kinases for cancer therapy. New Jersey: Wiley, 2010. p. 1-74. ISBN 978-0-470-22965-1.

CANCER; QUINASE; FOSFORILACAO DE PROTEINAS; PROTEINAS QUINASES HUMANAS. CLASSIFICACAO; TIROSINA QUINASE; RECEPTOR DA TIROSINA QUINASE; RECEPTOR DA TIROSINA QUINASE. CLASSIFICACAO; TIROSINA QUINASE DO NAO-RECEPTOR; GRUPO TKL; GRUPOM STE; GRUPO CSNK1; GRUPO AGC; GRUPO CAMK; GRUPO CMGC; CINASES CICLICAS DEPENDENTES (CDK); PROTEINA QUINASE ATIVADA POR MITOGENO (MAPK); GLICOGENIO SINTASE QUINASE (GSK); GRUPO RECEPTOR GUANILATO CICLASE; PROTEINAS QUINASES ATIPICAS; QUINASES. PROPRIEDADES; ESTRATEGIAS TERAPEUTICAS

3/17US=94 / Biol/Mol
Matthews DJ, Gerritsen ME. Protein kinase structure, function, and regulation. In: ___. Targeting protein kinases for cancer therapy. New Jersey: Wiley, 2010. p. 75-117. ISBN 978-0-470-22965-1.

QUINASE; QUINASE. ESTRUTURA; RECEPTORES TIROSINA QUINASE (RTK); FATOR DE CRESCIMENTO EPIDERMICO (EGF); INSULINA; IGF1; IGF1R; FATORES DE CRESCIMENTO DE FIBROBLASTOS (FGF); FATOR DE CRESCIMENTO VASCULAR ENDOTELIAL (VEGF); ANGIOPOIETINA-2; EPHRIN; DOMINIO TRANSMEMBRANA; QUINASE. FUNCAO; PROTEINA QUINASE. ATIVIDADE CATALITICA; PROTEINA QUINASE. CARACTERIZACAO CINETICA; PROTEINA QUINASE. QUIMICA DE CATALISE; PROTEINA QUINASE. REGULACAO; REGULACAO VIA FOSFORILACAO; REGULACAO POR N-TERMINAL; FAMILIA QUINASE SRC; QUINASE DE ADESAO FOCAL (FAK); QUINASES CICLINA-DEPENDENTES (CDK)

4/17US=94 / Biol/Mol
Matthews DJ, Gerritsen ME. Cell cycle control. In: ___. Targeting protein kinases for cancer therapy. New Jersey: Wiley, 2010. p. 327-90. ISBN 978-0-470-22965-1.

CICLO CELULAR; QUINASES CICLICAS DEPENDENTES (CDK); CDK4; CDK6; CDK2; CDK3; CDK1; CDK10; CCRK; CDCH; PRODUCAO DE MRNA; CDK7; CDK8; CDK9; CDK11; CDK12; CDK13; CDK5; QUINASE CICLINA G-ASSOCIADOS (GAK); QUINASES MITOTICAS; QUINASE POLO-LIKE (PLK); AURORA-QUINASE; ATAXIA-TELANGIECTASIA MUTADO (ATM); ATAXIA TELANGIECTASIA E PROTEINA RAD3 RELACIONADOS (ATR); CHK1; CHK2; MAPKAPK2

5/17US=94 / Biol/Mol
Matthews DJ, Gerritsen ME. Intracellular signaling kinase inhibitors. In: ___. Targeting protein kinases for cancer therapy. New Jersey: Wiley, 2010. p. 567-621. ISBN 978-0-470-22965-1.

INIBIDORES DE QUINASES; SINALIZACAO INTRACELULAR; INIBIDORES MTOR; INIBIDORES PI3K; INIBIDORES RAF; INIBIDORES MEK; INIBIDORES CDK; CICLO CELULAR; INIBIDORES PLK; INIBIDORES QUINASE-AURORA; INIBIDORES PROTEINA QUINASE C

6/17US=13 / Biol/Mol
Pecorino L. The cell cycle. In: ___. Molecular biology of cancer: mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008. p. 95-112. ISBN 978-0-19-921148-7.

CICLO CELULAR; CICLINAS; QUINASES DEPENDENTES DE CICLINA; MECANISMOS DE REGULACAO CDK; CONTROLE G1; CONTROLE G2; CHEKPOINT MITOTICO; CINASES AURORA; CANCER; CICLINA DEPENDENTE DE INIBIDORES DE QUINASE; ALVOS CELULARES

7/17US=47 / Câncer
Yap TA, Molife LR, Bono JS. CDK inhibitors as anticancer agents. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 135-62. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

INIBIDORES DE CDK; AGENTES ANTICANCERIGENOS; CICLO CELULAR; CICLINA DEPENDENTE DE QUINASE; CICLINA; INIBIDOR; FLAVOPIRIDOL; UCN-01; E7070; SELICICLIB; BMS 387032; ZD 304709

8/17US=57 / Biol/Mol
Weinberg RA. pRb e o controle do relogio do ciclo celular. In: ___. A biologia do câncer. Porto Alegre: Artmed, 2008. p. 255-306. ISBN 978-85-363-1348-1.

PRB; RELOGIO DO CICLO CELULAR; CICLINA-CDK; ONCOPROTEINAS VIRAIS

9/17US=64 / Câncer
Dai Y, Grant S. CDK inhibitors in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 331-63. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

INIBIDORES DE CDK NO MIELOMA MULTIPLO; PROGRESSAO DO CICLO CELULAR; QUINASES DEPENDENTES DE CICLINA

10/17US=67 / Biol/Mol
Knights CD, Pestell RG. The cell cycle: therapeutic targeting of cell regulatory components and effector pathways in cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 3-32. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4.

CICLO CELULAR; SEGMENTACAO TERAPEUTICA; COMPONENTES CELULARES; VIAS REGULADORAS; CANCER; CICLINA DEPENDENTE DE QUINASE; INIBIDORES CDK; TERAPIA; ACETILACAO; P53; CICLINA D1; EGFR; HDAC; STI-571; FLAVOPIRIDOL; INIBIDOR CDK2

11/17US=58 / Câncer
Post SM, Quinás-Cardama A, Lozano G. Regulation of p53 activity and associated checkpoint controls. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 171-88. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6.

P53; MDM2; P19; TUMORIGENESE; CANCER; RAS; CICLO CELULAR; RB; CICLINA; CDK

12/17US=84 / Biol/Mol
Liu F. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: regulation of smad activity by phosphorylation. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 105-23. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3.

TGF-B; SMAD; FOSFORILACAO; FOSFATASE; QUINASE DO RECEPTOR; MAP QUINASE; CDK; CANCER

13/17US=57-B / Biol/Mol
Weinberg RA. pRb and control of the cell cycle clock. In: ___. The biology of cancer. New York: Garland Science, 2007. p. 255-306. ISBN 0-8153-4078-8.

PRB; CONTROLO DO RELOGIO DO CICLO CELULAR; CICLINA-CDK; ONCOPROTEINAS VIRAIS; FACTORES DE TRANSCRICAO E2F

14/17US=68 / Biol/Mol
Dent P, Hylemon PB, Grant S, Fisher PB. Approaches for monitoring signal transduction changes in normal and cancer cells. In: Fisher PB. Cancer genomics and proteomics: methods and protocols. New Jersey: Humana Press, 2007. p. 259-76. (Methods in Molecular Biology, 383) ISBN 978-1-58829-504-0.

TRANSDUCAO DE SINAL; MONITORAMENTO EM CELULAS NORMAIS; MONITORAMENTO EM CELULAS CANCEROSAS; QUINASE; FOSFORILACAO; FOSFORO ESPECIFICO; IMUNOPRECIPITACAO; ERK1/2; MAP QUINASE; JNK1/2; P38; AKT; RAF-1; B-RAF; CDK

15/17US=92 / Biol/Mol
Maclean KH, Cleveland JL. DNA damage response, signalling pathways, and tumorigenesis: interactions between Myc- and cyclin-dependent kinase inhibitors in cancer. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 223-41. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

MYC; CDK; INIBIDORES DE CDK; INK4; CIP/KIP; CICLINA

16/17US=14 / Urologia
Cote RJ, Lerner SP, Datar RH. Bladder and upper tract cancer: molecula biology and prognostic markers in bladder cancer. In: Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan WM. Comprehensive textbook of genitourinary oncology. 3ª ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 385-401. ISBN 978-0-7817-4984-0.

BEXIGA; CANCER DO TRATO SUPERIOR; BIOLOGIA MOLECULAR; MARCADORES PROGNOSTICOS; CANCER DE BEXIGA; VIA P53; GENE RETINOBLASTOMA; CICLINAS; QUINASES DEPENDENTES DA CICLINA; INIBIDORES DE CDK; ANGIOGENESE; RECEPTORES DO FATOR DE CRESCIMENTO; METILACAO DO DNA

17/17US=122 / Tese/FAP
Sá BCS. Criação de "tissue array" de melanomas cutâneos extensivos superficiais para estudo imunistoquímico de fatores ligados à proliferação e apoptose celular. São Paulo, 2005. 117 p. Dissertação(Mestrado)-Fundação Antonio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2005/BiancaCostaSoaresdeSa/BiancaCostaSoraesSamestrado.pdf

Curriculum Lattes

MELANOMA; ANALISE MICROARRAY; IMUNOHISTOQUIMICA; PROTEINA P16; CICLINA D1; PROTEINA CDK; PROTEINA DO RETINOBLASTOMA; PROTEINA P53